Skip to content

To evaluate the efficacy of a cosmetic/ayurvedic formulation in the treatment of Miliaria (Prickly Heat)

An open label, single centered study to evaluate the efficacy of a cosmetic/ayurvedic formulation in the treatment of Miliaria (Prickly Heat) on affected children subjects.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/07/003822
Enrollment
35
Registered
2013-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Miliaria (Prickly Heat)

Interventions

Intervention1: CPL/PHP/0213: Baseline (day 1), day 3 and day 5.Sufficient quantity of the product shall be dusted on to cover the affected area properly.The product will be applied twice daily for a p

Sponsors

CHOLAYIL PVT LTD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Volunteer in generally good health. 2.Volunteer between the ages of 05 to 12 years. 3.Volunteer with primary miliaria. 4.Volunteer has not participated in a similar clinical investigation in the past four weeks. 5.Volunteer willing to abstain from using any cosmetic/medical product on the test site during the entire study course. 6.Volunteer willing to visit the site on scheduled visit. 7.Volunteer willing to give a sign a written assent form and come for regular observation.

Exclusion criteria

Exclusion criteria: 1.A known history or present condition of allergic response to any cosmetic products. 2.Skin disease except Miliaria (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations), which would interfere with the test readings. 3.Medications (e.g. steroids or antihistamines), which would compromise the study. 4.Currently or has been undergoing dermatologist treatments or procedures within the last 1 month. 5.Volunteer viewed by the investigator as not being able to complete the study or participating in another study.

Design outcomes

Primary

MeasureTime frame
To ascertain the efficacy of the investigational product in reducing the miliaria.Timepoint: Baseline (day 1), day 3 and day 5.

Secondary

MeasureTime frame
Reducing irritationTimepoint: Baseline (day 1), day 3 and day 5.

Countries

India

Contacts

Public ContactMs Meghana Surve

KETs Scientific Research Centre

meghana@kelkarcosmetology.com02225639644

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026